Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2011

View Archived Issues

PLATO subanalysis finds ticagrelor superior to clopidogrel in elderly patients with ACS

Interim first-in-human data disclosed on BioFreedom biolimus A9-eluting coronary stent

CTS-1027 shows promise to treat hepatitis C in treatment-naive and -experienced patients

Preclinical and clinical data presented on GS-9620 for hepatitis B and C

Cephalon advances in acquisition of ChemGenex Pharmaceuticals

New antibody-drug conjugate AGS-22M6E may be beneficial for treatment of solid tumors

Novel PI3K-alpha inhibitors patented by Roche for cancer

Merck KGaA designs new protein kinase inhibitors

Galderma synthesizes novel ADAM 17 inhibitors

Hyaluronidase-4 described as new predictor of bladder cancer progression

Anaphore's DR4 Atrimers have antitumor activity in vitro

Oryzon Genomics designs new inhibitors of lysine-specific histone demethylase 1A

Roche presents new inhibitors of HCV NS3 and NS4A

Biosearch designs new voltage-gated Na(V)1.3 and Na(V)1.8 sodium channel blockers

Phase III MARQUEE trial of tivantinib begins enrollment in Europe

VISTA-16 study of varespladib proceeds as planned after independent biomarker analysis

Novartis withdraws MAA for Joicela in osteoarthritis

GSK and Valeant Pharma submit response to FDA on ezogabine

Bristol-Myers Squibb begins phase I study of BMS-906024 in solid tumors

Celgene begins phase III trials of pomalidomide in multiple myeloma

AIDS Healthcare Foundation urges Gilead to halt Truvada approval in HIV prevention

NicOx withdraws European application for osteoarthritis candidate naproxcinod

Chugai Pharma receives priority review for Pegasys in new indication in chronic hepatitis B in Japan

FDA grants orphan status to AM-152 in idiopathic pulmonary fibrosis

CoDa Therapeutics raises funds for Nexagon trial

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026